Stockreport

Hansa Biopharma interim report January-March 2024 [Yahoo! Finance]

Gain Therapeutics, Inc.  (GANX) 
PDF Evan Ballantyne joins Hansa Biopharma as Chief Financial Officer LUND, Sweden April 18, 2024 /PRNewswire/ -- Hansa Biopharma, the pioneer in immunomodulatory enzyme t [Read more]